<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16370</article-id><article-id pub-id-type="doi">10.7554/eLife.16370</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>DPP9 is a novel component of the N-end rule pathway targeting the Tyrosine Kinase Syk</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-67118"><name><surname>Justa-Schuch</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55340"><name><surname>Silva-Garcia</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55337"><name><surname>Pilla</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55338"><name><surname>Engelke</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55339"><name><surname>Kilisch</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42213"><name><surname>Lenz</surname><given-names>Christof</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0946-8166</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55341"><name><surname>Möller</surname><given-names>Ulrike</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55342"><name><surname>Nakamura</surname><given-names>Fumihiko</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3313"><name><surname>Urlaub</surname><given-names>Henning</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-53028"><name><surname>Geiss-Friedlander</surname><given-names>Ruth</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1720-3440</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular Biology</institution>, <institution>University Medical Center Goettingen</institution>, <addr-line><named-content content-type="city">Goettingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution>MRC Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Institute of Cellular and Molecular Immunology</institution>, <institution>University Medical Center Goettingen</institution>, <addr-line><named-content content-type="city">Goettingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Bioanalytics, Institute of Clinical Chemistry</institution>, <institution>University Medical Center Goettingen</institution>, <addr-line><named-content content-type="city">Goettingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff5"><institution content-type="dept">Hematology Division, Department of Medicine, Brigham and Women's Hospital</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1087"><name><surname>Freeman</surname><given-names>Matthew</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>rgeiss@gwdg.de</email> (RG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>09</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e16370</elocation-id><history><date date-type="received"><day>24</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>07</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Justa-Schuch et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Justa-Schuch et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-16370-v1.pdf"/><abstract><p>The aminopeptidase DPP9 removes dipeptides from N-termini of substrates having a proline or alanine in second position. Although linked to several pathways including cell survival and metabolism, the molecular mechanisms underlying these outcomes are poorly understood. We identified a novel interaction of DPP9 with Filamin A, which recruits DPP9 to Syk, a central kinase in B-cell signalling. Syk signalling can be terminated by degradation, requiring the ubiquitin E3 ligase Cbl. We show that DPP9 cleaves Syk to produce a neo N-terminus with serine in position 1. Pulse-chases combined with mutagenesis studies reveal that Ser1 strongly influences Syk stability. Furthermore, DPP9 silencing reduces Cbl interaction with Syk, suggesting that DPP9 processing is a prerequisite for Syk ubiquitination. Consistently, DPP9 inhibition stabilizes Syk, thereby modulating Syk signalling. Taken together, we demonstrate DPP9 as a negative regulator of Syk and conclude that DPP9 is a novel integral aminopeptidase of the N-end rule pathway.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>2234/1-2</award-id><principal-award-recipient><name><surname>Geiss-Friedlander</surname><given-names>Ruth</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Heidenreich von Siebold-Programm, Universitaetsmedizin Goettingen</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Geiss-Friedlander</surname><given-names>Ruth</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-16370-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>